Whole exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma-Reference-Cited by-同舟云学术

Whole exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma

Published:2012-10-11 Issue:10 Volume:3 Page:1194-1203
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kannan Kasthuri¹²,Inagaki Akiko³,Silber Joachim¹²,Gorovets Daniel¹²,Zhang Jianan¹²,Kastenhuber Edward R.¹²,Heguy Adriana²,Petrini John H.³,Chan Timothy A.⁴²,Huse Jason T.¹²

Affiliation:

1. Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

2. Department of Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

3. Department of Molecular Biology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

4. Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 195 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Developments in Parasellar Tumors and Potential Therapeutic Implications;Endocrine Reviews;2024-07-26

2. Pan-cancer multi-omics analysis of PTBP1 reveals it as an inflammatory, progressive and prognostic marker in glioma;Scientific Reports;2024-06-25

3. The 2021 World Health Organization Central Nervous System Tumor Classification: The Spectrum of Diffuse Gliomas;Biomedicines;2024-06-18

4. Molecular Pathology of Gliomas;Clinics in Laboratory Medicine;2024-06

5. FANCM Gene Variants in a Male Diagnosed with Sertoli Cell-Only Syndrome and Diffuse Astrocytoma;Genes;2024-05-28